Renaissance Technologies
AGL icon

Renaissance Technologies’s Agilon Health AGL Stock Holding History

Renaissance Technologies’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
152,214
+3,171
+2% +$208K 0.02% 801
2026
Q1 		$1.18M Buy
149,043
+54,202
+57% +$876K ﹤0.01% 2177
2025
Q4 		$1.63M Buy
94,841
+36,457
+62% +$707K ﹤0.01% 1993
2025
Q3 		$1.5M Buy
58,384
+24,384
+72% +$921K ﹤0.01% 2253
2025
Q2 		$1.96M Sell
34,000
-17,640
-34% -$1.41M ﹤0.01% 2127
2025
Q1 		$5.59M Buy
51,640
+33,108
+179% +$2.88M 0.01% 1358
2024
Q4 		$880K Buy
18,532
+11,268
+155% +$681K ﹤0.01% 2565
2024
Q3 		$714K Buy
+7,264
New +$938K ﹤0.01% 2622
2024
Q2 		– Sell
-11,392
Closed -$1.74M – 3454
2024
Q1 		$1.74M Buy
11,392
+7,892
+225% +$1.31M ﹤0.01% 2126
2023
Q4 		$1.1M Sell
3,500
-16,412
-82% -$5.94M ﹤0.01% 2347
2023
Q3 		$8.84M Sell
19,912
-47,268
-70% -$21.4M 0.02% 989
2023
Q2 		$29.1M Buy
67,180
+65,756
+4,618% +$37M 0.04% 499
2023
Q1 		$846K Sell
1,424
-11,556
-89% -$6.47M ﹤0.01% 2580
2022
Q4 		$5.24M Buy
+12,980
New +$6.09M 0.01% 1492
2022
Q3 		– Sell
-6,012
Closed -$3.28M – 3990
2022
Q2 		$3.28M Buy
+6,012
New +$3.04M ﹤0.01% 1853
2022
Q1 		– Sell
-464
Closed -$313K – 4045
2021
Q4 		$313K Buy
+464
New +$282K ﹤0.01% 3323

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies's AGL Position: Q2 2026 in Review

Renaissance Technologies increased its Agilon Health (AGL) stake by 2.1% in Q2 2026, buying an estimated $208K and bringing the position to 152,214 shares worth $16.3M. The position accounts for 0.02% of the portfolio, ranked #801.

Renaissance Technologies first reported a position in AGL in Q4 2021 and has held it in 16 quarters since. The position peaked at $29.1M in Q2 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Renaissance Technologies held 152,214 shares of Agilon Health worth $16.3M as of Q2 2026.
  • Renaissance Technologies bought 3,171 Agilon Health shares in Q2 2026, an estimated $208K.
  • Agilon Health made up 0.02% of Renaissance Technologies's portfolio in Q2 2026, its #801 holding.
  • Renaissance Technologies first reported a position in Agilon Health in Q4 2021 and has held it in 16 quarters since.
  • Renaissance Technologies's Agilon Health position peaked at $29.1M in Q2 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.